SecBot SecBot
SECBOTREPLAY Home › Report › CRL

CRL · Charles River Laboratories announced the planned divestiture of its…

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 8-K filed Feb 25, 2026 at 07:34 ET

At the news

MIXEDIMPACT 7/10

8-K filed Feb 25, 2026 at 07:34 ET

Charles River Laboratories announced the planned divestiture of its CDMO and Cell Solutions businesses to GI Partners for contingent payments, and certain European Discovery Services assets to IQVIA for $145 million in cash plus up to $10 million in additional payments. The company updated its 2026 guidance, expecting the transactions to reduce reported revenue by over $200 million but improve non-GAAP EPS by ~$0.10 and add 100 basis points to non-GAAP operating margin.

  • Divesting CDMO and Cell Solutions businesses to GI Partners for future contingent payments; combined 2025 revenue of $143 million
  • Divesting European Discovery Services assets to IQVIA for $145 million cash plus up to $10 million in additional payments; 2025 revenue of $144 million
  • Both transactions expected to close in Q2 2026
  • Planned divestitures to reduce 2026 reported revenue by slightly more than $200 million

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access